Restrictive lung disease and serum TGF-β1 in thalassemia major children

Asian Pacific Journal of Allergy and Immunology

Volumn 23, Issue 2-3, 2005, Pages 121-126

  Sritippayawan, Suchada ^a   Lekhanont, Piyachat ^a   Harnruthakorn, Chanthana ^a   Samransamruajkit, Rujipat ^a   Deerojanawong, Jitladda ^a   Seksarn, Panya ^a   Poovorawan, Yong ^a   Prapphal, Nuanchan ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; FERRITIN; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; AIRWAY OBSTRUCTION; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; MALE; SCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THAILAND; THALASSEMIA MAJOR;

ADOLESCENT; BETA-THALASSEMIA; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; CHILD; CHILD WELFARE; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HUMANS; LUNG DISEASES; MALE; THAILAND; TOTAL LUNG CAPACITY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 27544499998     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. McDonagh KT, Nienhuis AW. The thalassemias. In: Nathan DG, Oski FA, 4th ed. Hematology of infancy and childhood. Philadelphia: W.B. Saunders Company, 1993; pp. 783-879.
2. Arora M, Chandra J, Suri JC, Narayan S, Dutta AK. Pulmonary function tests in beta-thalassemia. Indian J Pediatr 2001; 68: 239-42.
3. Filosa A, Esposito V, Meoli I, Stefanelli F, Cassandro R. Evidence of restrictive spirometric pattern in older thalassemic patients. Respiration 2001; 68: 237-8.
4. Kanj N, Shamseddine A, Gharzeddine W, et al. Relation of ferritin levels to pulmonary function in patients with thalassemia major and the acute effects of transfusion. Eur J Hematol 2000; 64: 396-400.
5. Dimopoulou I, Kremastinos DT, Maris TG, Mavrogeni S, Tzelepis GE. Respiratory function in patients with thalassemia and iron overload. Eur Respir J 1999; 13: 602-5.
6. Tai DYH, Wang YT, Lou J, Wang WY, Mak KH, Cheng HK. Lungs in thalassemia major patients receiving regular transfusion. Eur Respir J 1996; 9: 1389-94.
7. Factor JM, Pottipati SR, Rappaport I, Rosner IK, Lesser ML, Giardina PJ. Pulmonary function abnormalities in thalassemia major and the role of iron overload. Am J Respir Crit Care Med 1994; 149: 1570-74.
8. Grisaru D, Rachamilewitz EA, Mosseri M, et al. Cardiopulmonary assessment in beta-thalassemia major. Chest 1990; 98: 1138-42.
9. Fung KP, Chow OKW, So SY, Yuen PMB. Pulmonary function in thalassemia major. J Pediatr 1987; 111: 534-7.
10. Cooper DM, Mansell AL, Weiner MA, et al. Low lung capacity and hypoxemia in children with thalassemia major. Am Rev Respir Dis 1980; 121: 639-46.
11. Li AM, Chan D, Li CK, Wong E, Chan YL, Fok TF. Respiratory function in patients with thalassemia major: relation with iron overload. Arch Dis Child 2002; 87: 328-30.
12. Filosa A, Esposito V, Meoli I, Baron I, Romano L. Evidence of lymphocyte alveolitis by bronchoalveolar lavage in thalassemic patients with pulmonary dysfunction. Acta Haematol 2000; 103: 90-5.
13. Keens TG, O'Neal MH, Ortega JA, Hyman CB, Platzker ACG. Pulmonary function abnormalities in thalassemia patients on a hypertransfusion program. Pediatrics 1980; 65: 1013-7.
14. Hoyt RW, Sacrpa N, Wilmott RW, Cohen A, Schwartz E. Pulmonary function abnormalities in homozygous β-thalassemia. J Pediatr 1986; 109: 452-5.
15. Carnelli V, D'Angelo E, Pecchiari M, Ligorio M, D'Angelo E. Pulmonary dysfunction in transfusion-dependent patients with thalassemia major. Am J Respir Crit Care Med 2003; 168: 180-4.
16. Zakynthinos E, Vassilakopoulos T, Kaltsas P. et al. Pulmonary hypertension, interstitial fibrosis, and lung iron deposition in thalassemia major. Thorax 2001; 56: 737-9.
17. Abbas AK, Lichtman AH. Cellular and Molecular Immunology, 5th edition. Philadelphia: Saunders, 2003: 269-70.
18. Yong SJ, Adlakha A, Limper AH. Circulating transforming growth factor-β 1: a potential marker of disease activity during idiopathic pulmonary fibrosis. Chest 2001; 120: 688-70S.
19. Cao B, Guo Z, Zhu Y, Xu W. The potential role of PDGF, IGF-1, TGF-beta expression in idiopathic pulmonary fibrosis. Chin Med J (Engl) 2000; 113: 776-82.
20. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor-β in human disease. New Eng J Med 2000; 342: 1350-8.
21. Kotecha S, Wangoo A, Silverman M, Shaw RJ. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr 1996; 128: 464-9.
22. Freedman MH, Grisaru D, Olivieri N, MacLusky I, Thorner P. Pulmonary syndrome in patients with thalassemia major receiving intravenous desferoxamine. Arch J Dis Child 1990; 144: 565-9.
23. American Thoracic Society. Standardization of spirometry 1994 update. Am J Resp Crit Care Med 1995; 152: 1107-36.
24. Ries AL. Measurement of lung volumes. Clin Chest Med 1989; 10: 177-86.
25. Ruppel G. Manual of pulmonary function testing, 4th edition. St. Louis: The C.V. Mosby Company, 1986.
26. Luyt DK, Richards GA, Roode H, et al. Thalassemia: lung function with reference to iron studies and reactive oxidant status. Pediatr Hematol Oncol 1993; 10: 13-23.
27. Cappell DF, Hutchinson HE, Jowett M. Transfusional siderosis: the effects of excessive iron deposits on the tissues. J Path Bact 1957; 74: 245-64.
28. Witzleben CL, Wyatt JP. The effect of long survival on the pathology of thalassemia major. J Pathol Bacteriol 1961; 82: 1-13.
29. Salsaa B, Zoumbos NC. A distinct pattern of cytokine production from blood mononuclear cells in multitransfused patients with β-thalassemia. Clin Exp immunol 1997; 107: 589-92.